“Nuclear-Targeted Engineering of a Lunasin-Derived Peptide Enhances Antiproliferative Activity and AP-1-Associated Gene Modulation in A549 Lung Cancer Cells” (2026) Al Mustansiriyah Journal of Pharmaceutical Sciences, 26(3), pp. 331–353. doi:10.32947/ajps.v26i3.1404.